川聖貿易股份有限公司

主成分
Rosuvastatin Calcium contains not less than 98.0% and not more than 102.0% of (C22H27FN3O6S)2˙Calcium, calculated on the anhydrous basis. 
適應症
高膽固醇血症、高三酸甘油酯血症
主成分
Epirubicin Hydrochloride contains not less than 97.0% and not more than 102.0% of C27H30ClNO11, calculated on the anhydrous substance. 
適應症
抗腫瘤藥
主成分
90.0% to 105.0% of the peptide C145H240N44O48S2 (anhydrous and acetic acid-free substances). By convention, for the purpose of labeling Calcitonin (Salmon) preparation, 1 mg of Calcitonin (Salmon) (C145H240N44O48S2) is equivalent to6000 IU if biological activity. 
適應症
高血鈣危象、骨骼的帕哲特氏症
主成分
Tamsulosin Hydrochloride contains NL98.5% and NMT101.0% of (C20H28N2O5S‧HCl), calculated on the dried basis. 
適應症
前列腺肥大症伴隨的排尿障礙
主成分
Mometasone Furoate contains not less than 97.0% and not more than 102.0% of C27H30Cl2O6, calculated on the dried basis.  
適應症
腎上腺皮質類固醇
主成分
Flunarizine Dihydrochloride contains not less than 99.0% and not more than 101.5% of C26H26F2N2‧2HCl, calculated on the dried basis. 
適應症
鈣離子致效劑
主成分
Aceclofenac contains not less than 99.0% and not more than 101.0% of C16H13Cl2NO4, calculated on the dried basis. 
適應症
消炎鎮痛藥
主成分
Nifedipine contains not less than 98.0% and not more than 102.0% of C17H18N2O6, calculated on the dried basis. 
適應症
鈣離子封阻劑心絞痛治療藥
主成分
Pentoxifylline contains not less than 99.0% and not more than 101.0% of C13H18N4O3. 
適應症
周圍血管舒張劑
主成分
Hydrocortisone sodium succinate contains not less than 97.0% and not more than 102.0% of total steroids, calculated as C25H33NaO8, on the dried basis. 
適應症
抗炎性皮質固醇
主成分
Vortioxetine Hydrobromide(β-form) contains NLT 98.0% and NMT 102.0% of C18H22N2S‧HBr, calculated on the anhydrous substance. 
適應症
抗憂鬱劑
主成分
Pirfenidone contains not less than 98.0 % and not more than 102.0% of C12H11NO, calculated on the dried substance. 
適應症
治療特發性肺纖維化用藥
主成分
Valsartan contains not less than 99.0% and not more than 101.0% of C24H29N5O3, calculated on the anhydrous basis. 
適應症
降血壓劑
主成分
 
適應症
平滑肌鬆弛劑
主成分
Nifedipine contains not less than 98.0% and not more than 102.0% of C17H18N2O6, calculated on the dried basis. 
適應症
鈣離子封阻劑心絞痛治療藥
主成分
Lansoprazole contains not less than 99.0% and not more than 101.0% of C16H14F3N3O2S, calculated on the anhydrous substance. 
適應症
消化性潰瘍
主成分
Carvedilol contains NLT 99.0% and NMT 101.0% of C24H26N2O4, calculated on the dried basis. 
適應症
高血壓,鬱血性心臟衰竭
主成分
Etodolac contains not less than 98.0% and not more than 102.0% of C17H21NO3, calculated on the anhydrous basis. 
適應症
消炎鎮痛藥
主成分
Duloxetine Hydrochloride contains not less than 97.5% and not more than 102.0% of C18H19NOS‧HCl, calculated on the dried basis. 
適應症
抗憂鬱藥
主成分
Ipratropium Bromide contains not less than 99.0% and not more than 100.5% of C20H30BrNO3‧H2O, calculated on the anhydrous substances. 
適應症
慢性阻塞性支氣管炎、支氣管氣喘
主成分
Terbutaline Sulfate contains not less than 98.0% and not more than 101.0% of C24H40N2O10S, calculated on the dried substances. 
適應症
支氣管擴張劑
主成分
PREDNISOLONE 
適應症
抗炎性皮質固醇。
主成分
Linagliptin contains not less than 98.0% and not more than 102.0% of C25H28N8O2, calculated on anhydrous basis. 
適應症
降血糖藥
主成分
Famotidine contains not less than 98.5% and not more than 101.0% of C8H15N7O2S3, calculated on the dried basis.  
適應症
組織胺H2接受體拮抗劑
主成分
DEXAMETHASONE SODIUM PHOSPHATE 
適應症
醣類代謝皮質素。
主成分
PREDNISOLONE 
適應症
抗炎性皮質固醇。
主成分
Carvedilol contains NLT 99.0% and NMT 101.0% of C24H26N2O4, calculated on the dried basis. 
適應症
抗心律不整藥
主成分
DEXAMETHASONE 
適應症
抗炎性皮質固醇。
主成分
PREDNISOLONE ACETATE 
適應症
抗炎性皮質固醇。
主成分
Methylprednisolone contains not less than 97.0% and not more than 103.0% of C22H30O5, calculated on the dried basis. 
適應症
抗炎性皮質固醇。
主成分
Ezetimibe contains NLT 98.0% and NMT 102.0% of ezetimibe (C24H21F2NO3), calculated on the anhydrous and solvent-free basis. 
適應症
高膽固醇血症
主成分
BETAMETHASONE 
適應症
醣類代謝皮質素。
主成分
HYDROCORTISONE ACETATE 
適應症
腎上腺皮質固醇。
主成分
Posaconazole (Form- I) contains not less than 98.0% and not more than 102.0% of C37H42F2N8O4, calculated on the dried basis. 
適應症
抗黴菌劑
主成分
Canagliflozin Hemihydrate contains not less than 98.0% and not more than 102.0% of C24H25FO5S‧1/2H2O, calculated on the dried substance. 
適應症
降血糖用藥
主成分
Tenofovir Disoproxil Fumarate contains NLT 98.0% and NMT 102.0% of Tenofovir Disoproxil Fumarate (C19H30N5O10P‧C4H4O4), calculated on the dried basis. 
適應症
抗病毒藥
主成分
Carteolol Hydrochloride contains NLT 99.0% and NMT 101.0% of Carteolol Hydrochloride (C16H24N2O3‧HCl), calculated on the dried basis. 
適應症
擬交感神經beta接受體遮斷藥
主成分
Nicardipine Hydrochloride contains NLT 98.0% and NMT 101.0% of nicardipine hydrochloride (C26H29N3O6‧HCl), calculated on the dried basis.  
適應症
高血壓用藥
主成分
HYDROCORTISONE 
適應症
抗炎性皮質醇。
主成分
Hydrocortisone Acetate contains not less than 97% and not more than 102% of C23H32O6 calculated on the dried basis. 
適應症
腎上腺皮質固醇。
主成分
Irbesartan contains not less than 98.0% and not more than 102.0% of C25H28N6O, calculated on the dried basis. 
適應症
降血壓藥
主成分
Pantoprazole Sodium contains NLT 98.0% and NMT 102.0% of C16H14F2N3NaO4S.3/2 H2O, calculated on the anhydrous substance. 
適應症
氫離子幫浦抑制劑
主成分
Febuxostat (Form A) contains NLT 98.0% and NMT 102.0% of C16H16N2O3S, calculated on the anhydrous substance. 
適應症
高尿酸血症用藥
主成分
Dapagliflozin Propanediol (Monohydrate) contains not less than 98.0% and not more than 102.0% of C21H25C1O6・C3H8O2・H2O, calculated on the dried basis. 
適應症
降血糖用藥
主成分
Lenalidomide contains NLT 98% and NMT 102% of Lenalidomide (C13H13N3O3), calculated on the anhydrous and solvent-free basis. 
適應症
抗癌藥
主成分
,Sorafenib Tosylate contains not less than 97.0% and not more than 102.0% of C21H16CIF3N4O3·C7H8O3S. 
適應症
抗腫瘤藥
主成分
Etoricoxib contains NLT 98.0% and not NMT 102.0% of C18H15ClN2O2S, calculated on the anhydrous substance. 
適應症
消炎止痛
主成分
Dasatinib Monohydrate contains NLT 98.0% and NMT 102.0% of Dasatinib Monohydrate (C22H26ClN7O2S.H2O), calculated on the anhydrous and solvent-free basis.  
適應症
白血病用藥
主成分
Dutasteride contains NLT 97.0% and NMT 102.0% of Dutasteride (C27H30F6N2O2), calculated on the dried basis. 
適應症
良性攝護腺增生之治療,雄性素致效劑
主成分
Saxagliptin Monohydrate contains NLT 98.0% and NMT 102.0% of C18H25N3O2・H2O, calculated on the anhydrous substance. 
適應症
第二型糖尿病
主成分
Parecoxib Sodium contains NLT 98.0% and NMT 102.0% of C19H17N2NaO4S, calculated on the anhydrous substance. 
適應症
使用於外科手術後疼痛之緩解
主成分
Aceclofenac (Process-II) contains not less than 99.0 % and not more than 101.0 % of C16H13Cl2NO4, calculated on the dried substance. 
適應症
消炎鎮痛藥
主成分
Tadalafil contains not less than 97.5% and not more than 102.0% of C22H19N3O4, calculated on the dried substance. 
適應症
男性勃起障礙治療
主成分
Agomelatine(Form I) contains NLT 98.0% and not NMT 102.0% of C15H17NO2, calculated on the anhydrous substance. 
適應症
抗憂鬱劑
主成分
Letrozole contains NLT 98.0% and NMT 102.0% of C17H11N5, calculated on the anhydrous basis. 
適應症
非固醇性抗雌激素藥
主成分
Agomelatine (Form II) contains NLT 98.0% and NMT 102.0% of C15H17NO2, calculated on the anhydrous substance. 
適應症
抗憂鬱劑
主成分
Pioglitazone Hydrochloride contains not less than 98.0% and not more than 102.0% of C19H20N2O3S‧HCl, calculated on the anhydrous basis. 
適應症
糖尿病治療藥
主成分
Paliperidone contains not less than 98.0% and not more than 102.0% of C23H27FN4O3, calculated on dried basis. 
適應症
思覺失調症、情感思覺失調症
主成分
BETAMETHASONE VALERATE 
適應症
副腎皮質荷爾蒙劑
主成分
TRIAMCINOLONE 
適應症
副腎皮質荷爾蒙劑
主成分
BETAMETHASONE 
適應症
副腎皮質苛爾蒙劑
主成分
BETAMETHASONE DIPROPIONATE 
適應症
副腎皮質荷爾蒙
主成分
LOVASTATIN 
適應症
抗高血脂症。
主成分
FLUOROMETHOLONE 
適應症
副賢皮質荷爾蒙劑
主成分
GINKGO BILOBA EXTRACT 
適應症
末梢血管循環障礙。
主成分
PROPRANOLOL HCL 
適應症
抗心律不整藥、擬交感神經BATA-接受體遮斷藥。
主成分
Methylprednisolone contains not less than 97.0% and not more than 103.0% of C22H30O5, calculated on the dried basis. 
適應症
抗炎性皮質固醇。
主成分
Triamcinolone Acetonide contains not less than 97.0% and not more than 103.0% of C24H31FO6, calculated on the dried basis. 
適應症
抗炎性皮質固醇藥。
主成分
CLOTRIMAZOLE 
適應症
抗真菌劑
主成分
ATENOLOL 
適應症
B型交感神經阻斷劑。
主成分
Dopamine Hydrochloride contains not less than 99% and not more than 101% of C8H11NO2?HCl, calculated on the dried basis. 
適應症
擬交感神經興奮藥。
主成分
Betamethasone Valerate contains not less than 97.0%and not more than 103.0% of C27H37FO6,calculated on the dried basis. 
適應症
抗炎性皮質醇(外用)。
主成分
Carvedilol contains not less than 99.0% and not more than 101.0% of C24H26N2O4, calculated on the dried substance. 
適應症
降血壓藥、心臟用藥。
主成分
Betamethasone Sodium Phosphate contains not less than 96.0% and not more than 103.0% of C22H28FNa2O8P calculated on the dried basis. 
適應症
抗炎性皮質固醇。
主成分
Betamethasone Dipropionate contains not less than 97.0% and not more than 103% of C28H37FO7 calculated on the dried basis. 
適應症
副腎皮質荷爾蒙。
主成分
Scopolamine Butyl bromide contains not less than 98.0% and not more than 101.0% of C21H30BrNO4, calculated on the dried basis. 
適應症
副交感神經抑制劑
主成分
 
適應症
糖尿病。
主成分
Tacrolimus contains not less than 98.0% and not more than 102.0% of C44H69NO12, calculated on the dried basis. 
適應症
免疫抑制劑。
主成分
PRAVASTATIN SODIUM 
適應症
降血脂劑。
主成分
Atorvastatin Calcium contains not less than 98.0% and not more than 102.0% of C66H68CaF2N4O10 ,calculated on the dried basis. 
適應症
降血脂藥。
主成分
Piolitazone Hydrochloride contains not less than 98.0% and not more than 102% of C19H20N2O3S?HCl, calculated on the dried basis. 
適應症
糖尿病。
主成分
Venlafaxine Hydrochloride contains not less than 99.0% and not more than 101.0% of C17H28ClNO2, calculated on the dried basis. 
適應症
憂鬱症、泛焦慮症
主成分
Irbesartan contains not less than 98.0% and not more than 102.0% of C25H28N6O, calculated on the dried basis. 
適應症
降血壓劑
主成分
Diltiazem Hydrochloride contains not less than 98.5% and not more than 101.0% of C22H27ClN2O4S, calculated on the dried basis. 
適應症
鈣離子拮抗劑
主成分
PIROXICAM 
適應症
消炎鎮痛藥。
主成分
Orlistat contains not less than 98.0% and not more than 101.0% of C29H53NO5, calculated on the dried basis. 
適應症
抗肥胖劑。
主成分
Escitalopram Oxalate contains not less than 98.0% and not more than 102.0% of C20H21FN2O.C2H2O4, calculated on the anhydrous basis. 
適應症
憂鬱症之治療及預防復發。
主成分
SIMVASTATIN 
適應症
血脂調節劑。
主成分
FENOTEROL HYDROBROMIDE 
適應症
支氣管擴張劑。
主成分
TOLNAFTATE 
適應症
局部抗黴菌劑。
主成分
Donepezil Hydrochloride contains not less than 98.0% and not more than 102.0% of C24H29NO3˙HCl, calculated on the anhydrous basis. 
適應症
阿滋海默氏症
主成分
Betaxolol Hydrochloride contains not less than 98.5% and not more than 101.5% of C18H29NO3‧HCl, calculated on the dried substances. 
適應症
擬交感神經β接受體遮斷藥。
主成分
Doxorubicin Hydrochloride contains not less than 98.0% and not more than 102.0% of C27H29NO11.HCl, calculated on the dried basis. 
適應症
抗癌藥
主成分
Aripiprazole contains not less than 98.0% and not more than 102.0% of C23H27Cl2N3O2, calculated on the anhydrous basis. 
適應症
抗精神病藥物。
主成分
Olanzapine contains not less than 98.0% and not more than 102.0% of C17H20N4S, calculated on the anhydrous basis. 
適應症
精神分裂症
主成分
Risperidone contains not less than 99.0% and not more than 101.0% of C23H27FN4O2, calculated on the dried basis. 
適應症
精神異常引起之相關症狀。
主成分
Quetiapine Fumarate contains not less than 98.5% and not more than 101.0% of (C21H25N3O2S)2 C4H4O4, calculated on the anhydrous basis. 
適應症
抗精神病藥物。
主成分
Zoledronic acid monohydrate contains not less than 98.0% and not more than 101.0% of C5H10N2O7P2‧H2O, calculated on the dried basis. 
適應症
惡性腫瘤之高血鈣症
主成分
Acyclovir contains not less than 99.0 and not more than 101% of C8H11N5O3, calculated on the anhydrous basis. 
適應症
抗病毒劑。
主成分
Clioquinol contains not less than 98% and not more than 102% of C9H5ClINO, calculated on the dried basis. 
適應症
局部抗感染藥
主成分
Cilostazol contains not less than 98.0% and not more than 102.0% of C20H27N5O2 calculated on the dried basis. 
適應症
抗血栓;緩解間歇性跛足的症狀。
主成分
Budesonide is a mixture of two epimeric forms, epimer A (C-22S) and epimer B (C-22R).\nIt contains not less than 40.0% and not more than 51.0% of epimer A, and sum of both epimers is not less than 98.0% and not more than 102.0% of C25H34O6, calculated on the dried basis. 
適應症
抗炎性皮質固醇
主成分
Clopidogrel Bisulfate contains not less than 99.0% and not more than 101.0% of C16H16ClNO2S˙H2SO4, calculated on the dried basis. 
適應症
抗凝血劑
主成分
Losartan Potassium contains not less than 98.5% and not more than 101.0% of C22H22ClKN6O calculated on the anhydrous, solvent-free basis. 
適應症
降血壓劑。
主成分
Paroxetine Hydrochloride Hemihydrate contains not less than 98.5% and not more than 102.0% of C19H21ClFNO3‧1/2H2O, calculated on the anhydrous substance. 
適應症
治療憂鬱症、強迫症、恐慌症藥
主成分
Clopidogrel Bisulfate contains not less than 97.0% and not more than 101.5% of C16H16ClNO2‧H2SO4, calculated on the dried basis. 
適應症
抗凝血劑
主成分
Quetiapine Hemifumarate contains not less than 98.0% and not more than 102.0% of C42H50N6O4S2‧C4H4O4, calculated on the anhydrous basis. 
適應症
抗精神病藥物。
主成分
Pitavastatin Calcium (pentahydrate) contains not less than 98.0% and not more than 102.0% of (C25H23FNO4)2Ca・5H2O, calculated on the anhydrous basis. 
適應症
血脂調節劑
主成分
Sulfadiazine Silver contains not less than 98.0% and not more than 102.0% of C10H9AgN4O2S, calculated on the dried basis. 
適應症
外用抗菌藥
主成分
Olmesartan Medoxomil contains NLT 98.5% and NMT 101.5% of C29H30N6O6, calcualted on the anhydrous and solvent-free basis. 
適應症
高血壓
主成分
Febuxostat hemihydrate contains NLT 98.0% and NMT 102.0% of C16H16N2O3S.1/2 H2O, calculated on the anhydrous substance. 
適應症
高尿酸血症用藥
主成分
Simvastatin contains not less than 98.0% and not more than 101.0% of C25H38O5, calculated on the dried basis. It may contain a suitable antioxidant. 
適應症
降血脂劑
主成分
Mirabegron contains NLT 98.0% and NMT 102.0% of Mirabegron (C21H24N4O2S), calculated on the anhydrous and solvent-free basis. 
適應症
β3-腎上腺接受體作用劑
主成分
Pitavastatin Calcium (Hydrate) contains not less than 98.0% and not more than 102.0% of (C25H23 FNO4)2Ca, calculated on the anhydrous substance. 
適應症
血脂調節劑
主成分
Clopidogrel Bisulfate contains not less than 97.0% and not more than 101.5% of C16H16ClNO2S‧H2SO4, calculated on the dried basis. 
適應症
抗血栓劑
主成分
Pitavastatin Calcium contains not less than 98.0% and not more than 101.0% of (C25H23FNO4)2‧Ca, calculated on the anhydrous substance. 
適應症
血脂調節劑